Low temperature enhancement of reporter genes expression directed by human immunodeficiency virus type 1 long terminal repeat. 1996

M Chevrier-Miller, and M Morange, and A P Arrigo, and M Pinto
Ecole Normale Supérieure, CNRS-URA 1302, Paris, France.

Bacteria and eukaryotic cells respond to cold stress by inducing and enhancing the synthesis of specific arrays of proteins. We describe here cold-induced enhancement of expression for two reporter genes; luciferase and beta-galactosidase, both under the control of HIV-1 LTR sequences, observed in mouse fibroblasts and human HeLa cells respectively. Increased expression of luciferase in fibroblasts when shifted to 25 degrees C was detectable at 30 degrees C but was not observed following cold shock at 4 degrees C. To sustain the cold-induced effect, cells had to be kept at subphysiological temperature. The observed enhancement of luciferase activity did not result from a particular site of integration of the reporter gene and was evident whether cold-stressed cells were stationary or growing. Cold-induced expression of luciferase was evidenced at the protein level, enzymatic activity and RNA level, furthermore, active transcription and translation were required for overexpression. The cold effect which has been generalized with the reporter gene beta-galactosidase appears to be a process involving, at least in part, the HIV-1 LTR sequences and might correspond to an increase in the half-life of mRNA. The cold-dependent enhanced expression of luciferase and beta-galactosidase reported here, together with data describing the activation of HIV-1 LTR by hyperthermia, point out the particular temperature sensitivity of these regulatory sequences. This potential thermal modulation may be useful in the comprehension of regulatory processes in latency and reactivation of viral expression during HIV-1 infection.

UI MeSH Term Description Entries
D008156 Luciferases Enzymes that oxidize certain LUMINESCENT AGENTS to emit light (PHYSICAL LUMINESCENCE). The luciferases from different organisms have evolved differently so have different structures and substrates. Luciferase
D003080 Cold Temperature An absence of warmth or heat or a temperature notably below an accustomed norm. Cold,Cold Temperatures,Temperature, Cold,Temperatures, Cold
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001616 beta-Galactosidase A group of enzymes that catalyzes the hydrolysis of terminal, non-reducing beta-D-galactose residues in beta-galactosides. Deficiency of beta-Galactosidase A1 may cause GANGLIOSIDOSIS, GM1. Lactases,Dairyaid,Lactaid,Lactogest,Lactrase,beta-D-Galactosidase,beta-Galactosidase A1,beta-Galactosidase A2,beta-Galactosidase A3,beta-Galactosidases,lac Z Protein,Protein, lac Z,beta D Galactosidase,beta Galactosidase,beta Galactosidase A1,beta Galactosidase A2,beta Galactosidase A3,beta Galactosidases
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015967 Gene Expression Regulation, Viral Any of the processes by which cytoplasmic factors influence the differential control of gene action in viruses. Regulation of Gene Expression, Viral,Viral Gene Expression Regulation,Regulation, Gene Expression, Viral
D016325 HIV Long Terminal Repeat Regulatory sequences important for viral replication that are located on each end of the HIV genome. The LTR includes the HIV ENHANCER, promoter, and other sequences. Specific regions in the LTR include the negative regulatory element (NRE), NF-kappa B binding sites , Sp1 binding sites, TATA BOX, and trans-acting responsive element (TAR). The binding of both cellular and viral proteins to these regions regulates HIV transcription. HIV Negative Regulatory Element,HIV Sp1-Binding Site,HIV Trans-Acting Responsive Region,Human Immunodeficiency Virus Long Terminal Repeat,Long Terminal Repeat, HIV,Negative Regulatory Element, HIV,Sp1-Binding Site, HIV,Trans-Acting Responsive Region, HIV,HIV-1 LTR,Human Immunodeficiency Virus LTR,LTR, Human Immunodeficiency Virus,TAR Element, HIV,Trans-Activation Responsive Element, HIV,Trans-Activation Responsive Region, HIV,HIV 1 LTR,HIV Sp1 Binding Site,HIV Sp1-Binding Sites,HIV TAR Element,HIV TAR Elements,HIV Trans Acting Responsive Region,LTR, HIV-1,Sp1 Binding Site, HIV,Sp1-Binding Sites, HIV,TAR Elements, HIV,Trans Acting Responsive Region, HIV,Trans Activation Responsive Element, HIV,Trans Activation Responsive Region, HIV

Related Publications

M Chevrier-Miller, and M Morange, and A P Arrigo, and M Pinto
March 1993, Proceedings of the National Academy of Sciences of the United States of America,
M Chevrier-Miller, and M Morange, and A P Arrigo, and M Pinto
June 1990, Journal of virology,
M Chevrier-Miller, and M Morange, and A P Arrigo, and M Pinto
November 1987, Biochemical and biophysical research communications,
M Chevrier-Miller, and M Morange, and A P Arrigo, and M Pinto
April 1992, Journal of virology,
M Chevrier-Miller, and M Morange, and A P Arrigo, and M Pinto
January 1994, Progress in nucleic acid research and molecular biology,
M Chevrier-Miller, and M Morange, and A P Arrigo, and M Pinto
May 1997, Leukemia research,
M Chevrier-Miller, and M Morange, and A P Arrigo, and M Pinto
December 1990, Journal of virology,
M Chevrier-Miller, and M Morange, and A P Arrigo, and M Pinto
September 1989, Journal of virology,
M Chevrier-Miller, and M Morange, and A P Arrigo, and M Pinto
December 1998, Journal of reproductive immunology,
Copied contents to your clipboard!